Back to resultsPatient's Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph's Hospital)
Primary Purpose
Coagulation Disorder
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
questionnaire via smartphone
Sponsored by
About this trial
This is an interventional other trial for Coagulation Disorder
Eligibility Criteria
Inclusion Criteria:
- patient under ant-thrombotic treatment
- hospitalized in vascular medecine service
Exclusion Criteria:
- refusing the participation
Sites / Locations
- Groupe Hospitalier Paris Saint Joseph
Outcomes
Primary Outcome Measures
smartphone use level
evaluation of the interest of patient to use their smartphone in the purpose to follow their anticoagulant treatment
Secondary Outcome Measures
Full Information
NCT ID
NCT03304977
First Posted
September 29, 2017
Last Updated
October 3, 2017
Sponsor
Fondation Hôpital Saint-Joseph
1. Study Identification
Unique Protocol Identification Number
NCT03304977
Brief Title
Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph's Hospital)
Official Title
Current Situation of the Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment in GHPSJ (St Joseph's Hospital)
Study Type
Interventional
2. Study Status
Record Verification Date
September 2017
Overall Recruitment Status
Completed
Study Start Date
June 6, 2016 (Actual)
Primary Completion Date
July 31, 2016 (Actual)
Study Completion Date
October 30, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation Hôpital Saint-Joseph
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Oral antigoagulant are used more than 60 years in thrombotic diseases. Even they are indispensable, the haemorragic risk is high.That's why it's the main reason of hospitalization for iatrogeny.The complication's reasons are mainly linked to errors of drug intake, drugs interaction and the lack of understanding the treatment.Moreover, the antiplatelet agglutening treatment is frequently added to anticoagulant treatment.This increases the haemorragic risk.Different means were used to minimize the risk , like INR follow up.
The purpose of the study is to evaluate smartphone use to follow the patients'treatment.
Detailed Description
Two questionnaire via smartphone with 15 days gap.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coagulation Disorder
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Other
Intervention Name(s)
questionnaire via smartphone
Intervention Description
questionnaire via smartphone
Primary Outcome Measure Information:
Title
smartphone use level
Description
evaluation of the interest of patient to use their smartphone in the purpose to follow their anticoagulant treatment
Time Frame
15 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patient under ant-thrombotic treatment
hospitalized in vascular medecine service
Exclusion Criteria:
refusing the participation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pascal PRIOLLET, MD
Organizational Affiliation
GHPSJ
Official's Role
Study Director
Facility Information:
Facility Name
Groupe Hospitalier Paris Saint Joseph
City
Paris
State/Province
Ile-de-France
ZIP/Postal Code
75014
Country
France
12. IPD Sharing Statement
Learn more about this trial
Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph's Hospital)
We'll reach out to this number within 24 hrs